Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Resources > Multimedia > Phyllis Arthur


Availability of Medical Countermeasures and US Biosecurity

Behind the Scenes in Biosecurity-Video Interviews with Leaders in the Field

September 17, 2012


Speaker: Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization

The timely availability of medical countermeasures-drugs, vaccines and other medical resources needed for a robust response-is a key component of US biosecurity. Ms. Arthur discusses the role of public-private partnerships in drug and vaccine development and production and broadly outlines the roles that Congress, the Administration, and the private sector play regarding US biodefense policy.

As a senior leader at the Biotechnology Industry Organization (BIO), Ms. Arthur has a unique and critical role at the interface between the resources and requirements of the US government and the research, development, manufacturing, and production capabilities of private industry.



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.